LGALS9 and cancer: During acute immune responses, Tim-3 enhances NK cytotoxicity and IFN-γ production [34], while in chronic inflammation or cancer, its engagement—particularly by Galectin-9—suppresses NK activity and cytokine production, contributing to immune exhaustion [35].